A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection by Pollin Toni I, Damcott Coleen M, Shen Haiqing, Ott Sandra H, Shelton John, Horenstein Richard B, Post Wendy, McLenithan John C, Bielak Lawrence F, Peyser Patricia A, Mitchell Braxton D, Miller Michael, O'Connell Jeffrey R, Shuldiner Alan R in Science (New York, N.Y.) (2008).

[PMID: 19074352] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.